Amarin Case Demonstrates Limits Of ITC Jurisdiction
Law360, New York (November 22, 2017, 12:23 PM EST) -- In what represents a departure from typical U.S. International Trade Commission (ITC) practice, the ITC on Oct. 27, 2017, declined to institute a Section 337 investigation based on a complaint brought by Amarin Pharma Inc. and Amarin Pharmaceuticals Ireland Ltd. ("Amarin"). The commission's non-institution decision (as well as a brief concurring memorandum from Commissioner Meredith Broadbent) provides incremental insight into the question of the ITC's jurisdiction and deference to sister government agencies.
Section 337 broadly authorizes the ITC to investigate all forms of "[u]nfair methods of competition and unfair acts in the importation of articles." This breadth of authority makes...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!